메뉴 건너뛰기




Volumn 13, Issue 8, 2013, Pages 2201-2206

Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations

Author keywords

Complement factor I; gene mutation; hemolytic uremic syndrome; kidney transplantation; membrane cofactor protein; Shiga toxin

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR I; CYCLOSPORIN A; MEMBRANE COFACTOR PROTEIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VEROTOXIN;

EID: 84881374227     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12297     Document Type: Article
Times cited : (47)

References (30)
  • 1
    • 70350279315 scopus 로고    scopus 로고
    • Atypical hemolytic-uremic syndrome
    • Noris M, Remuzzi G., Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676-1687.
    • (2009) N Engl J Med , vol.361 , pp. 1676-1687
    • Noris, M.1    Remuzzi, G.2
  • 2
    • 15244348050 scopus 로고    scopus 로고
    • Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
    • Tarr PI, Gordon CA, Chandler WL., Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073-1086.
    • (2005) Lancet , vol.365 , pp. 1073-1086
    • Tarr, P.I.1    Gordon, C.A.2    Chandler, W.L.3
  • 3
    • 77957550498 scopus 로고    scopus 로고
    • Complement in typical hemolytic uremic syndrome
    • Orth D, Wurzner R., Complement in typical hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36: 620-624.
    • (2010) Semin Thromb Hemost , vol.36 , pp. 620-624
    • Orth, D.1    Wurzner, R.2
  • 5
    • 80053645340 scopus 로고    scopus 로고
    • A new health threat in Europe: Shiga toxin-producing Escherichia coli O104: H4 infections
    • Wu CJ, Hsueh PR., Ko WC., A new health threat in Europe: Shiga toxin-producing Escherichia coli O104: H4 infections. J Microbiol Immunol Infect 2011; 44: 390-393.
    • (2011) J Microbiol Immunol Infect , vol.44 , pp. 390-393
    • Wu, C.J.1    Hsueh, P.R.2    Ko, W.C.3
  • 6
    • 0034980687 scopus 로고    scopus 로고
    • Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells
    • O'Loughlin EV, Robins-Browne RM., Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microb Infect 2001; 3: 493-507.
    • (2001) Microb Infect , vol.3 , pp. 493-507
    • O'Loughlin, E.V.1    Robins-Browne, R.M.2
  • 7
    • 18744414483 scopus 로고    scopus 로고
    • Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1
    • Zoja C, Angioletti S, Donadelli R, et al. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 2002; 62: 846-856.
    • (2002) Kidney Int , vol.62 , pp. 846-856
    • Zoja, C.1    Angioletti, S.2    Donadelli, R.3
  • 8
    • 0035885951 scopus 로고    scopus 로고
    • Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress
    • Morigi M, Galbusera M, Binda E, et al. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 2001; 98: 1828-1835.
    • (2001) Blood , vol.98 , pp. 1828-1835
    • Morigi, M.1    Galbusera, M.2    Binda, E.3
  • 9
    • 0041411081 scopus 로고    scopus 로고
    • Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review of meta-analysis, and meta-regression
    • Garg AX, Suri RS, Barrowman N, et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review of meta-analysis, and meta-regression. JAMA 2003; 290: 1360-1370.
    • (2003) JAMA , vol.290 , pp. 1360-1370
    • Garg, A.X.1    Suri, R.S.2    Barrowman, N.3
  • 10
    • 38349172121 scopus 로고    scopus 로고
    • Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
    • Fang CJ, Fremeaux-Bacchi V, Liszewski MK, et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 2008; 111: 624-632.
    • (2008) Blood , vol.111 , pp. 624-632
    • Fang, C.J.1    Fremeaux-Bacchi, V.2    Liszewski, M.K.3
  • 11
    • 77958587405 scopus 로고    scopus 로고
    • Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
    • Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5: 1844-1859.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 1844-1859
    • Noris, M.1    Caprioli, J.2    Bresin, E.3
  • 12
    • 67651166873 scopus 로고    scopus 로고
    • Mutations in thrombomodulin in hemolytic-uremic syndrome
    • Delvaeye M, Noris M, DeVriese A, et al. Mutations in thrombomodulin in hemolytic-uremic syndrome. N Engl J Med 2009; 361: 345-357.
    • (2009) N Engl J Med , vol.361 , pp. 345-357
    • Delvaeye, M.1    Noris, M.2    Devriese, A.3
  • 13
    • 75649133611 scopus 로고    scopus 로고
    • Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
    • Moore I, Strain L, Pappworth I, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 2010; 115: 379-387.
    • (2010) Blood , vol.115 , pp. 379-387
    • Moore, I.1    Strain, L.2    Pappworth, I.3
  • 14
    • 34047200899 scopus 로고    scopus 로고
    • Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
    • Zipfel PF, Edey M, Heinen S, et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 2007; 3: e41.
    • (2007) PLoS Genet , vol.3
    • Zipfel, P.F.1    Edey, M.2    Heinen, S.3
  • 15
    • 20544437666 scopus 로고    scopus 로고
    • Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome
    • Dragon-Durey MA, Loirat C, Cloarec S, et al. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16: 555-563.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 555-563
    • Dragon-Durey, M.A.1    Loirat, C.2    Cloarec, S.3
  • 16
    • 67650508077 scopus 로고    scopus 로고
    • The high frequency of complement factor H-related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome
    • Dragon-Durey MA, Blanc C, Marliot F, et al. The high frequency of complement factor H-related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet 2009; 46: 447-450.
    • (2009) J Med Genet , vol.46 , pp. 447-450
    • Dragon-Durey, M.A.1    Blanc, C.2    Marliot, F.3
  • 17
    • 33846668749 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome: A factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells
    • Heinen S, Jozsi M, Hartmann A, et al. Hemolytic uremic syndrome: A factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells. J Am Soc Nephrol 2007; 18: 506-514.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 506-514
    • Heinen, S.1    Jozsi, M.2    Hartmann, A.3
  • 18
    • 0035810399 scopus 로고    scopus 로고
    • Complement first of two parts
    • Walport MJ., Complement first of two parts. N Engl J Med 2001; 344: 1058-1066.
    • (2001) N Engl J Med , vol.344 , pp. 1058-1066
    • Walport, M.J.1
  • 19
    • 84867997580 scopus 로고    scopus 로고
    • STEC-HUS, atypical HUS and TTP are all diseases of complement activation
    • Noris M, Mescia F, Remuzzi G., STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 2012; 8: 622-633.
    • (2012) Nat Rev Nephrol , vol.8 , pp. 622-633
    • Noris, M.1    Mescia, F.2    Remuzzi, G.3
  • 20
    • 77954048044 scopus 로고    scopus 로고
    • Thrombotic microangiopathy after kidney transplantation
    • Noris M, Remuzzi G., Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010; 10: 1517-1523.
    • (2010) Am J Transplant , vol.10 , pp. 1517-1523
    • Noris, M.1    Remuzzi, G.2
  • 21
    • 0030049869 scopus 로고    scopus 로고
    • Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma
    • Remuzzi G, Galbusera M, Salvadori M, Rizzoni G, Paris S, Ruggenenti P., Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma. Kidney Int 1996; 49: 282-286.
    • (1996) Kidney Int , vol.49 , pp. 282-286
    • Remuzzi, G.1    Galbusera, M.2    Salvadori, M.3    Rizzoni, G.4    Paris, S.5    Ruggenenti, P.6
  • 23
    • 33745812440 scopus 로고    scopus 로고
    • Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome
    • Fremeaux-Bacchi V, Moulton EA, Kavanagh D, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2006; 17: 2017-2025.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 2017-2025
    • Fremeaux-Bacchi, V.1    Moulton, E.A.2    Kavanagh, D.3
  • 24
    • 77952682366 scopus 로고    scopus 로고
    • Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome
    • Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ., Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 2010; 31: E1445-E1460.
    • (2010) Hum Mutat , vol.31
    • Maga, T.K.1    Nishimura, C.J.2    Weaver, A.E.3    Frees, K.L.4    Smith, R.J.5
  • 25
    • 0036952936 scopus 로고    scopus 로고
    • Shiga toxin-associated hemolytic uremic syndrome: Absence of recurrence after renal transplantation
    • Ferraris JR, Ramirez JA, Ruiz S, et al. Shiga toxin-associated hemolytic uremic syndrome: Absence of recurrence after renal transplantation. Pediatr Nephrol 2002; 17: 809-814.
    • (2002) Pediatr Nephrol , vol.17 , pp. 809-814
    • Ferraris, J.R.1    Ramirez, J.A.2    Ruiz, S.3
  • 26
    • 0026666338 scopus 로고
    • Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome
    • Robson WL, Leung AK, Fick GH, McKenna AI., Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 1992; 62: 296-299.
    • (1992) Nephron , vol.62 , pp. 296-299
    • Robson, W.L.1    Leung, A.K.2    Fick, G.H.3    McKenna, A.I.4
  • 27
    • 79960435714 scopus 로고    scopus 로고
    • Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis
    • Morigi M, Galbusera M, Gastoldi S, et al. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 2011; 187: 172-180.
    • (2011) J Immunol , vol.187 , pp. 172-180
    • Morigi, M.1    Galbusera, M.2    Gastoldi, S.3
  • 28
  • 29
    • 80052473232 scopus 로고    scopus 로고
    • Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome
    • Weitz M, Amon O, Bassler D, Koenigsrainer A, Nadalin S., Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol 2011; 26: 1325-1329.
    • (2011) Pediatr Nephrol , vol.26 , pp. 1325-1329
    • Weitz, M.1    Amon, O.2    Bassler, D.3    Koenigsrainer, A.4    Nadalin, S.5
  • 30
    • 77951876953 scopus 로고    scopus 로고
    • Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome
    • Zimmerhackl LB, Hofer J, Cortina G, et al. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med 2010; 362: 1746-1748.
    • (2010) N Engl J Med , vol.362 , pp. 1746-1748
    • Zimmerhackl, L.B.1    Hofer, J.2    Cortina, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.